LIPID FORMULATIONS OF AMPHOTERICIN-B - LESS TOXICITY BUT AT WHAT ECONOMIC COST

被引:50
作者
TOLLEMAR, J
RINGDEN, O
机构
[1] Departments of Transplantation Surgery and Clinical Immunology, Huddinge Hospital, Karolinska Institutet, Stockholm, Huddinge
关键词
D O I
10.2165/00002018-199513040-00001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:207 / 218
页数:12
相关论文
共 85 条
[1]  
Bodey G., Bueltman B., Duguid W., Et al., Fungal infections in cancer patients: an international autopsy survey, Eur J Microbiol Infect Dis, 11, pp. 99-109, (1992)
[2]  
Meunier F., Fungal infections in the compromised host, Clinical approach to infection in the compromised host, pp. 193-220, (1989)
[3]  
Meyers J.D., Fungal infections in bone marrow transplant patients, Semin Oncol, 17, (1990)
[4]  
Denning D.W., Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host, J Antimicrob Chemother, 28, pp. 1-16, (1991)
[5]  
Tollemar J., Invasive fungal infections — incidence, diagnosis, risk-factors and treatment in bone marrow and liver transplant recipients [dissertation], (1991)
[6]  
Gallis H.A., Drew R.H., Pickard W.W., Amphotericin B: 30 years of clinical experience, Rev Infect Dis, 12, (1990)
[7]  
Holleran W.M., Wilbur J.R., De Gregorio M.W., Empiric amphotericin B therapy in patients with acute leukemia, Rev Infect Dis, 7, (1985)
[8]  
Medoff G., Brajtburg J., Kobayashi G.S., Antifungal agents useful in therapy of systemic fungal infections, Ann Rev Pharmacol Toxicol, 2, (1983)
[9]  
Odds F.C., Candida and candidosis, (1988)
[10]  
Dick J.D., Metz W.G., Sarai R., Incidence of polyene-resistant yeasts recovered from clinical specimens, Antimicrob Chemother, 18, (1980)